Last week, Evolve had the privilege of participating in the 37th European Renal Cell Study Group (ERCSG) 2025 Meeting, hosted by Universitätsmedizin Greifswald. The event brought together leading researchers, clinicians, and medical innovators from around the world to share the latest advancements in nephrology.
From Scientific Discovery to Market Success
At Evolve, we’re passionate about helping biotech, tech, and lifescience companies turn groundbreaking science into commercially viable solutions. Our Managed Finance (hyperlink) and Advisory Solutions (hyperlink) provide the financial infrastructure and operational readiness needed to move from research to real-world impact.
Throughout the event, we engaged with industry leaders, academic institutions, and regulators to explore how finance can accelerate innovation – and how strong financial operations can be a catalyst for scientific progress.
A Global Event With Local and International Sponsors
We were honored to be part of this inspiring event alongside a strong lineup of regional and global supporters, including:
- Deutsche Forschungsgemeinschaft (DFG)
- Save the Kidney
- NIPOKA GmbH
- Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern mbH
- EUROIMMUN
- MICROMUN GmbH
- MediBeacon Inc.
- cells/MDPI
- Sparkasse Vorpommern
- Ottersche Stiftung für nephrologische Forschung
- Sebia
- Förderverein Pommersche Heimat e.V.
Follow us on LinkedIn to keep up with the latest events and happenings.
